ArticleeLife2016
Salicylate, diflunisal and their metabolites inhibit CBP/p300 and exhibit anticancer activity.
Kotaro Shirakawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
46 papers cite it
this papercites it
ArticleeLife2016
Kotaro Shirakawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.